Teva Pharmaceutical Industries Ltd. (TEVA: Quote) Friday said it launched an authorized generic of Actoplus Met, or pioglitazone/metformin tablets, in US.
Actoplus met is marketed by Takeda Pharmaceuticals U.S.A Inc. and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Actoplus met had annual sales of about $413 million in the US, based on IMS sales data as of June 30, 2012.
Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Limited and others in your portfolio
by RTT Staff Writer
For comments and feedback: email@example.com